Fig 5 - حسب Mary J. Obayemi (11813022)

Reduced ADAMTS-12 expression levels decrease EVT invasion. حسب Alexander G. Beristain (225001)

Higher baseline PV rates decrease the need for interneuron specialization. حسب Joram Keijser (12475353)

Early increase and later decrease in GSK-3β activity. حسب Arie J. Hoogendijk (353624)

Brain uptake of [¹⁴C]docosahexaenoic acid (DHA) in 2-, 8-, 12-, and 24-month-old mice. حسب Takuro Iwao (14636741)

الموضوعات:

Decrease of actin velocity when passing confined TCR clusters. حسب Cheng-han Yu (244912)

Cellular uptake of [¹⁴C]docosahexaenoic acid (DHA) by RBECs transfected with MFSD2A siRNA. حسب Takuro Iwao (14636741)

الموضوعات:

Fig 5 - حسب Jacob C. Jentzer (4746999)

Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses to Ensovibep vs placebo day 1–90. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Study Flow Diagram. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Ageing results in an abrupt decrease in overall neurogenesis in the mouse DG. حسب Joana Gil-Mohapel (462002)

"…(C) An estimation of overall neurogenesis based on the total number of BrdU-positive cells that survived the 42-day period multiplied by the proportion of BrdU-positive cells that acquired a mature neuronal phenotype indicates an age-induced significant and abrupt decrease in the overall number of new neurons. *** <i>p</i> < 0.001 between 1.5 and 3 months and between 3 and 6 months. …"

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Decrease of full-length tRNAs under oxidative stress. حسب Jiayong Zhong (757895)

"…The data are shown as the mean ± SD. (C) Decreased tRNA levels following 30 min of OS, measured by next-generation sequencing. …"

Long-term anti-nucleocapsid response by baseline patient characteristics. حسب Elizabeth S. Munroe (21568166)

الموضوعات: